NEW YORK (PRWEB) : Probuphine: formidable hurdles will severaly limit adoption

Posted by:

The FDA recently approved Probuphine, an implantable form of buprenorphine, for longer term maintenance treatment to address opiate withdrawal and opiate craving post opiate detoxification. Addiction expert, Dr. Cidambi provides her take on Probuphine. Her view is that implementation is cumbersome and will likely limit the uptake of the medication.


About the Author:

New Jersey's premier addiction treatment center, offering medically managed detox and rehabilitation treatment programs.
  Related Posts
  • No related posts found.

Add a Comment